- 101. I05
- (UMLS (HL7) C1549881) =Intellectual Product =Message structure;
| - 151. ICD-10 Canada
- (UMLS (HL7) C1550219) =Intellectual Product =Code;
|
- 102. I05, I06
- (UMLS (HL7) C1549898) =Intellectual Product =Message structure;
| - 152. ICD-10 Procedure Codes
- [Procedure Coding System (ICD-10-PCS). See http://www/hcfa.gov/stats/icd10.icd10.htm for more information. ( HL7V3.0 )] (UMLS (HL7) C1550212) =Intellectual Product =Code;
CodeSystem |
- 103. I06
- (UMLS (HL7) C1549882) =Intellectual Product =Message structure;
| - 153. ICD-9CM
- [Commission on Professional and Hospital Activities, 1968 Green Road, Ann Arbor, MI 48105 (includes all procedures and diagnostic tests). ( HL7V3.0 )] (UMLS (HL7) C1550214) =Intellectual Product =Code;
CodeSystem |
- 104. I08, I09, I10, I11
- (UMLS (HL7) C1549897) =Intellectual Product =Message structure;
| - 154. ICD9
- [World Health Publications, Albany, NY. ( HL7V3.0 )] (UMLS (HL7) C1550213) =Intellectual Product =Code;
CodeSystem |
- 105. I08, I09. I10, I11
- (UMLS (HL7) C1549893) =Intellectual Product =Message structure;
| - 155. ICHPPC-2
- [International Classification of Health Problems in Primary Care, Classification Committee of World Organization of National Colleges, Academies and Academic Associations of General Practitioners (WONCA), 3rd edition. An adaptation of ICD9 intended for use in General Medicine, Oxford University Press. ( HL7V3.0 )] (UMLS (HL7) C1550217) =Intellectual Product =Code;
CodeSystem |
- 106. I12, I13, I14, I15
- (UMLS (HL7) C1549907) =Intellectual Product =Message structure;
| - 156. ichthyotoxin
- [ ] (UMLS (CSP) C0304166) =Amino Acid, Peptide, or Protein; Biologically Active Substance; Hazardous or Poisonous Substance
|
- 107. I3A
- [A selective small-molecule activator of protein kinase C (PKC) isolated from the plant Euphorbia peplus with potential antineoplastic activity. Ingenol 3-angelate (I3A) activates various protein kinase C (PKC) isoforms, thereby inducing apoptosis in some tumor cells, including myeloid leukemia cells, melanoma cells, and basal cell carcinoma cells. The PKC family consists of signaling isoenzymes that regulate many cell processes including proliferation, differentiation, and apoptosis. ( NCI )] (UMLS (NCI) C1456762) Ingenol 3-Angelate;
PEP005 =Organic Chemical; Pharmacologic Substance | - 157. ICI 123215
- (UMLS (NCI) C0701274) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 108. IA
- [Injection, intraarterial ( HL7V3.0 )] (UMLS (NCI) C0021487) =Functional Concept ;
=Injectable;
Intra-arterial =Injection, intraarterial, push;
Injection, intraarterial, slow push ◊ [A state in the northern midwest United States. Its capital is Des Moines. ( NCI )] (UMLS (NCI) C0022037) Geographic Area ; | - 158. ICI 176334
- (UMLS (NCI) C0740019) =Organic Chemical; Pharmacologic Substance
|
- 109. IACUC
- (UMLS (NCI) C1136114) Institutional Animal Care and Use Committee;
=Professional or Occupational Group ;
| - 159. ICI 182,780
- [A drug that blocks estrogen activity in the body and is used in the therapy of estrogen-dependent tumors such as breast cancer. ( NCI )] (UMLS (NCI) C1123005) ICI 182780 =Steroid; Pharmacologic Substance ;
|
- 110. IAP
- [Retroviral-like intracisternal A particles. High copy number family of repeated elements in the mouse with a typical proviral organization. Expressed very early in mouse development (2-8 cell stage) and in transformed cells. Mutant alleles of various genes contain newly-integrated IAP genes. ( NCI )] (UMLS (NCI) C0600253) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
| - 160. ICI 46,474
- (UMLS (NCI) C0700621) =Organic Chemical; Pharmacologic Substance ;
|
- 111. IAP Family Gene
- [Mammalian IAP Family Genes encode conserved Inhibitors of Apoptosis Proteins with an N-terminal domain containing 1-3 repeats of a 65-70-aa Cys- and His-rich BIR motif and often a zinc-binding RING finger. Some IAPs inhibit apoptosis by regulating ICE-like protease activation signals and/or inhibit serum deprivation-induced apoptosis. Some IAP proteins may bind to TRAF1 and TRAF2. IAP proteins are frequently over expressed in cancers and associated with resistance to therapy. (NCI) ( NCI )] (UMLS (NCI) C1334073) =Gene or Genome ;
| - 161. ICI 59118
- (UMLS (NCI) C0877950) ICRF 159;
ICRF159;
ICRF-159 =Organic Chemical; Pharmacologic Substance |
- 112. IAP Family Protein
- [Encoded by Mammalian IAP Family Genes, conserved (Inhibitors of Apoptosis) IAP Family Proteins exhibit an N-terminal domain containing 1-3 repeats of a 65-70-aa Cys- and His-rich BIR motif and often a zinc-binding RING finger. Some IAPs inhibit apoptosis by regulating ICE-like protease activation signals and/or inhibit serum deprivation-induced apoptosis. Some IAP proteins may bind to TRAF1 and TRAF2. IAP proteins are frequently over expressed in cancers and associated with resistance to therapy. (NCI) ( NCI )] (UMLS (NCI) C0893445) IAP Protein;
Inhibitor of Apoptosis Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 162. ICI D1033
- (UMLS (NCI) C0733865) ICI-D1033;
=Organic Chemical; Pharmacologic Substance ;
|
- 113. IATROGEN CV INFARC/HMRHG
- [ ] (UMLS (ICD9CM) C0375722) =Disease or Syndrome
| - 163. ICI D1694
- (UMLS (NCI) C0123106) =Organic Chemical; Pharmacologic Substance
|
- 114. IATROGEN HYPOTHYROID NEC
- (UMLS (ICD9CM) C0154160) =Disease or Syndrome
| - 164. ICI-118630
- (UMLS (NCI) C0701275) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 115. IATROGEN PULM EMB/INFARC
- [ ] (UMLS (ICD9CM) C0375266) =Disease or Syndrome
| - 165. Iclaprim
- (UMLS (NCI) C1452002) =Organic Chemical; ;
|
- 116. IATROGENC HYPOTNSION NEC
- [ ] (UMLS (ICD9CM) C1260414) Other iatrogenic hypotension =Pathologic Function
| - 166. ICM
- [between breakfast and lunch ( HL7V3.0 )] (UMLS (HL7) C1550746) =Temporal Concept =TimingEvent;
|
- 117. Iatrogenic Cancer
- [The development of a malignant neoplasm in response to medical or surgical treatment, induced by the treatment itself. ( NCI )] (UMLS (NCI) C0751625) Therapy Related Cancer;
Therapy Related Malignant Neoplasm;
Therapy Related Malignant Tumor =Neoplastic Process ;
| - 167. ICN 1229
- (UMLS (NCI) C0702025) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
|
- 118. IATROGENIC CARNITINE DEF
- (UMLS (ICD9CM) C1260391) Iatrogenic carnitine deficiency =Pathologic Function
| - 168. Icofungipen
- (UMLS (NCI) C1174269) =Amino Acid, Peptide, or Protein; ;
|
- 119. iatrogenic disease
- [adverse conditions occurring as the result of treatment by a health professional; especially infections acquired during the course of treatment. ( CSP )] (UMLS (CSP) C0020732) =Disease or Syndrome =Pathologic Process;
Disease Attributes | - 169. Icon
- [hybrid molecule specifically designed to deliver a toxin to a specific cell or tissue. ( CSP )] (UMLS (NCI) C0243020) =Pharmacologic Substance; Immunologic Factor =Ab;
|
- 120. Iatrogenic hypotension
- [ ] (UMLS (ICD9CM) C0375314) =Disease or Syndrome ;
| - 170. Icotidine
- (UMLS (NCI) C0063315) =Organic Chemical; Pharmacologic Substance
|
- 121. Iatrogenic Kaposi Sarcoma
- [A Kaposi sarcoma that develops after organ transplantation or immunosuppressive treatment. ( NCI )] (UMLS (NCI) C1334149) Iatrogenic Kaposi's Sarcoma =Neoplastic Process ;
| - 171. ICP/MS
- [A mass spectrometry technique that uses inductively-coupled plasma generated from argon gas to atomize and ionize a sample. The resulting ions are separated and analyzed using a mass spectrometer. ( NCI )] (UMLS (HL7) C1553183) ICPMS;
ICP-MS;
Inductively Coupled Plasma Mass Spectrometry;
Inductively-Coupled Plasma Mass Spectrometry =Laboratory Procedure =ObservationMethod;
|
- 122. IATROGENIC PITUITARY DIS
- (UMLS (ICD9CM) C0154198) =Disease or Syndrome
| - 172. ICP47
- [ ] (UMLS (CSP) C0599802) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 123. IATROGENIC PNEUMOTHORAX
- [ ] (UMLS (ICD9CM) C0375336) =Disease or Syndrome ;
| - 173. ICR
- (UMLS (NCI) C0025925) =Mammal ;
|
- 124. IATROGENIC THYROIDITIS
- (UMLS (ICD9CM) C0154163) =Disease or Syndrome
| - 174. ICRF-187
- (UMLS (NCI) C0733406) =Organic Chemical; Pharmacologic Substance
|
- 125. Ibandronate Sodium
- [The sodium salt form of ibadronic acid, a synthetic nitrogen-containing bisphosphonate. Ibandronic acid inhibits farnesyl pyrophosphate synthase, resulting in a reduction in geranylgeranyl GTPase signaling proteins and apoptosis of osteoclasts. This agent increases bone mineral density, decreases bone remodeling, inhibits osteoclast-mediated bone resorption, and reduces metastases-related and corticosteroid-related bone pain. ( NCI )] (UMLS (NCI) C0772244) =Organic Chemical; Pharmacologic Substance
| - 175. ICS 205-930
- (UMLS (NCI) C0701391) =Organic Chemical; Pharmacologic Substance
|
- 126. Ibandronic Acid
- [A third-generation amino-bisphosphonate with anti-resorptive and anti-hypercalcemic activity. Ibandronic acid binds to and adsorbs onto the surface of hydroxyapatite crystals in the bone matrix, thereby preventing osteoclast resorption. This agent also inhibits farnesyl pyrophosphate synthase, an enzyme involved in the mevalonate pathway. Inhibition of this enzyme prevents the formation of isoprenoids, thereby leading to a reduction in the farnesylation and geranylgeranylation of signaling proteins of G protein-coupled signaling, and, eventually, inducing apoptosis of osteoclasts. By inhibiting osteoclast-mediated bone resorption, ibandronic acid increases bone mineral density, decreases bone remodeling and turnover, as well as reduces bone pain. ( NCI )] (UMLS (NCI) C0379200) =Organic Chemical; Pharmacologic Substance
| - 176. ICSH
- [major gonadotropin secreted by the adenohypophysis; luteinizing hormone regulates steroid production by the interstitial cells of the gonads; the preovulatory luteinizing hormone surge in females induces ovulation and subsequent luteinization of the follicle. ( CSP )] (UMLS (CSP) C0023607) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone ;
=[HS400] GONADOTROPINS;
neuropeptide;
[HS000] HORMONES / SYNTHETICS / MODIFIERS;
=LUTEINIZING HORMONE 150 UNT;
LUTEINIZING HORMONE 75 UNT;
|
- 127. IBC
- [The capacity of iron-binding protein in serum (transferrin) to bind serum iron. ( NCI )] (UMLS (NCI) C0373658) =Laboratory Procedure
| - 177. Icterus
- [An observation that describes the icterus index of the specimen. It is recommended to use mMol/L of bilirubin ( HL7V3.0 )] (UMLS (HL7) C1553190) =Idea or Concept =ActSpecObsInterferenceCode;
|
- 128. IBD
- [chronic, non-specific inflammation of the gastrointestinal tract; etiology may be genetic or environmental. ( CSP )] (UMLS (NCI) C0021390) =Disease or Syndrome =Enteritis;
Intestinal Diseases =Colitis, Ulcerative;
Crohn Disease;
Colitis, Ulcerative;
Crohn Disease | - 178. ICV
- [between dinner and the hour of sleep ( HL7V3.0 )] (UMLS (HL7) C1550748) =Temporal Concept =TimingEvent;
|
- 129. Ibizan Hound
- [The Ibizan Hound is an agile, deer-like, athletic hound that has a long, arched neck, long wedge-shaped head, and very large, triangular ears which stand up when the dog is alert. The rose or flesh-colored nose has a slightly convex shape called "Roman nose." The Ibizan Hound is "hare-footed," with long toes. There are three varieties of Ibizan: smooth-haired, long-haired, and wire-haired. Colors are white and red, white and tan, or solid white or red. Height: 22-29 inches (56-74 cm.) Weight: 42-55 pounds (19-25 kg.) ( NCI )] (UMLS (NCI) C0324381) =Mammal
| - 179. ID
- [A state in the northern Rocky Mountains of western United States. Its capital is Boise. ( NCI )] (UMLS (NCI) C0020787) =Geographic Area ◊ [republic stretching from the Indian Ocean east to New Guinea, comprising six main islands: Java, Sumatra, Bali, Kalimantan (the Indonesian portion of the island of Borneo), Sulawesi (formerly known as the Celebes) and Irian Jaya (the western part of New Guinea); its capital is Djakarta. ( CSP )] (UMLS (NCI) C0021247) Geographic Area ; southeast Asia;
|
- 130. iboga alkaloid
- [ ] (UMLS (CSP) C0598647) =Organic Chemical; Pharmacologic Substance ;
| - 180. ID2
- [This gene plays a role in the regulation of both transcription and cell proliferation. ( NCI )] (UMLS (NCI) C1334077) ID2 Gene;
Inhibitor of DNA Binding 2, Dominant Negative Helix-Loop-Helix Protein Gene;
=Gene or Genome ;
|
- 131. ibogaine
- [indole alkaloid with antidepressant and euphoric properties; appears to modulate tolerance to opiates. ( CSP )] (UMLS (CSP) C0020737) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =alkaloid;
Indole;
psychotropic drug;
methoxyindole;
[XX000] MISCELLANEOUS AGENTS;
=IBOGAINE HYDROCHLORIDE;
| - 181. IDA/L-ATRA
- (UMLS (NCI) C0338250) =Therapeutic or Preventive Procedure
|
- 132. Ibopamine
- (UMLS (NCI) C0123043) =Organic Chemical; Pharmacologic Substance
| - 182. IDA/MP/MTX/PRED/VCR
- (UMLS (NCI) C0281018) =Therapeutic or Preventive Procedure
|
- 133. ibotenate
- [3-hydroxy-5-isoxazole alpha-aminoacetate, an excitatory aminoacid agonist for certain quisqualate-sensitive glutamate receptors in the brain; it is a neurotoxin that selectively ablates neuronal cell bodies while sparing axonal projections. ( CSP )] (UMLS (CSP) C0178705) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =alkaloid;
Amino Acids, Cyclic;
hallucinogen;
Fungal Toxin;
Neurotoxin;
EAA | - 183. Idarubicin HCl
- [The hydrochloride salt of the anthracycline antineoplastic antibiotic idarubicin. Idarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation. Due to its high lipophilicity, idarubicin HCL penetrates cell membranes better than other anthracycline antibiotics. (NCI04) ( NCI )] (UMLS (NCI) C0282388) =Organic Chemical; Pharmacologic Substance ;
=(1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy-alpha-L-hexopyranoside;
=IDARUBICIN HYDROCHLORIDE 5 MG;
IDARUBICIN HYDROCHLORIDE 10 MG;
IDARUBICIN HYDROCHLORIDE 20 MG;
IDARUBICIN HYDROCHLORIDE 1 MG/ML |
- 134. ibotenate receptor
- [ ] (UMLS (CSP) C0598524) =Amino Acid, Peptide, or Protein; Receptor
| - 184. IDEC C2B8 antibody
- [ ] (UMLS (CSP) C0295415) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 135. IBP2
- [Encoded by human IGFBP2 Gene, cysteine-rich high molecular weight secreted 328-aa 35-kD Insulin-Like Growth Factor-Binding Protein 2 precursor contains an IGFBP domain and a thyroglobulin type-I domain. IGF-binding proteins prolong plasma IGF half-life and alter IGF interaction with cell surface receptors. The predominant form in plasma (150-kD) contains IGF-BP53 with apparent molecular mass of 53-kD. IGFBP2 binds IGF-II with high affinity more than IGF-I. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0123257) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 185. IDEC Y2B8
- [A murine monoclonal antibody directed against the CD20 phosphoprotein, expressed on the cell surface of normal B-lymphocytes and B-cell lymphomas. ( NCI )] (UMLS (NCI) C0879283) IDEC-2B8;
IDEC-Y2B8 monoclonal antibody;
Murine Monoclonal Antibody 2B8 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor |
- 136. Ibritumomab Tiuxetan
- [An immunoconjugate of monoclonal antibody ibritumomab conjugated with the linker-chelator tiuxetan. Ibritumomab is a murine IgG1 kappa monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes. This linker-chelator provides a high affinity, conformation restricted chelation site for Indium-111 or Yttrium-90 to be used in relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma, including patients with rituximab refractory follicular non-Hodgkin's lymphoma. ( NCI )] (UMLS (NCI) C0877880) IBRITUMOMAB TIUXETAN PREPARATION;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =[AN600] ANTINEOPLASTIC RADIOPHARMACEUTICALS;
Unclassified Ingredients =IBRITUMOMAB TIUXETAN 1.6 MG/ML;
| - 186. IDEC-114 Monoclonal Antibody/Rituximab
- (UMLS (NCI) C1327912) =Therapeutic or Preventive Procedure ;
|
- 137. Ibudilast
- (UMLS (NCI) C0123047) =Organic Chemical; Pharmacologic Substance
| - 187. IDEC-In2B8/Rituximab
- (UMLS (NCI) C0796509) =Therapeutic or Preventive Procedure
|
- 138. IC
- [between meals (from lat. inter cibus) ( HL7V3.0 )] (UMLS (HL7) C1550740) =Temporal Concept =TimingEvent;
| - 188. IDEC-In2B8/Rituximab/Yttrium Y 90 Ibritumomab Tiuxetan
- (UMLS (NCI) C0935804) =Therapeutic or Preventive Procedure
|
- 139. IC
- [A country in Northern Europe, island between the Greenland Sea and the North Atlantic Ocean, northwest of the UK. (NCI) ( NCI )] (UMLS (NCI) C0020750) =Geographic Area
| - 189. Idem
- (UMLS (NCI) C0445247) =Qualitative Concept ;
|
- 140. Ic351
- (UMLS (NCI) C0967375) =Organic Chemical; Pharmacologic Substance ;
| - 190. Identical
- [Exactly alike; incapable of being perceived as different; being the exact same one; coinciding exactly when superimposed; having properties with uniform values along all axes. ( NCI )] (UMLS (NCI) C0205280) =Qualitative Concept
|
- 141. ICAM
- [ ] (UMLS (CSP) C0598077) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 191. identical twin
- [two offspring developed from one zygote or fertilized ovum and therefore having identical genomes. ( CSP )] (UMLS (CSP) C0041432) =Family Group =twin/multiplet;
|
- 142. ICAM1
- [This gene is involved in mediating integrin-binding interactions that result in cellular adhesion. ( NCI )] (UMLS (NCI) C1334074) ICAM1 Gene;
Intercellular Adhesion Molecule 1 (CD54), Human Rhinovirus Receptor Gene;
=Gene or Genome ;
| - 192. Identification
- [The procedure of having an identity established. ( NCI )] (UMLS (NCI) C0205396) =Qualitative Concept
|
- 143. ICAM2
- [This gene is involved in antigen-specific immune responses and NK-cell clearance. ( NCI )] (UMLS (NCI) C1334075) ICAM2 Gene;
Intercellular Adhesion Molecule 2 Gene;
=Gene or Genome ;
| - 193. Identification problem
- (UMLS (HL7) C1548778) =Qualitative Concept =Specimen Reject Reason;
|
- 144. ICAM3
- [This gene is involved in the mediation of cellular adhesion, immune responses, and signal transduction. ( NCI )] (UMLS (NCI) C1334076) ICAM3 Gene;
Intercellular Adhesion Molecule 3 Gene;
=Gene or Genome ;
| - 194. Identified
- (UMLS (HL7) C1550043) =Finding ;
=Container status;
◊ [Used by one system to inform another that it has received a container. ( HL7V3.0 )] (UMLS (HL7) C1551388) Functional Concept ActContainerRegistrationCode; |
- 145. ICC
- [An malignant tumor composed of cells resembling those of bile ducts. Cholangiocarcinoma is a relatively rare tumor in most populations. It can arise from any portion of the intrahepatic bile duct epithelium or the hepatic ducts. Grossly, the lesions are nodular, grayish-white firm and solid. Microscopically, the vast majority of cholangiocarcinomas are adenocarcinomas showing tubular and/or papillary structures. Early detection of cholangiocarcinomas is difficult, and the overall prognosis after resection is poor (adapted from WHO, 2000). —2002 ( NCI )] (UMLS (NCI) C0345905) =Neoplastic Process
| - 195. identified entity
- [Roles played by entities and scoped by entities that identify them for various purposes. ( HL7V3.0 )] (UMLS (HL7) C1555305) =Idea or Concept =RoleClassPassive;
|
- 146. ICCS
- (UMLS (HL7) C1611822) =Intellectual Product =Code;
◊ [Commission on Professional and Hospital Activities, 1968 Green Road, Ann Arbor, MI 48105. ( HL7V3.0 )] (UMLS (HL7) C1550220) Intellectual Product CodeSystem; | - 196. Identifier
- [For attributes that serve to identify some instance of an information model class. Note that real world Identifiers (e.g., SSN) exist not as attributes but as an association to a special information model class. The attribute type "id" without a prefix is reserved to be the main instance identifier of the class. ( HL7V3.0 )] (UMLS (HL7) C1554104) =Idea or Concept =MDFAttributeType;
◊ [Holds the unique identifier of use cases, interactions and storyboards. ( HL7V3.0 )] (UMLS (HL7) C1554159) Idea or Concept HL7DefinedRoseProperty; |
- 147. ICD
- [between lunch and dinner ( HL7V3.0 )] (UMLS (HL7) C1550747) =Temporal Concept =TimingEvent;
| - 197. Identifier type
- (UMLS (HL7) C1547613) =Idea or Concept =HL7 Vocabulary Version 2.5;
=American Express;
Account number;
Account number Creditor;
Account number debitor;
Anonymous identifier;
Temporary Account Number;
Advanced Practice Registered Nurse number;
Bank Account Number;
Bank Card Number;
Birth registry number;
Breed Registry Number;
Cost Center number;
County number;
Dentist license number;
Drug Enforcement Administration registration number;
Drug Furnishing or prescriptive authority Number;
Diner's Club card;
Driver's license number;
More… |
- 148. ICD
- [A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12). (NCI) ( NCI )] (UMLS (NCI) C0870733) International Classification of Diseases =Intellectual Product ;
| - 198. identity
- [aggregate of characteristics by which an individual is recognized by himself and others. ( CSP )] (UMLS (CSP) C0424215) =Mental Process =psychology;
=psychological identification;
|
- 149. ICD-10
- [World Health Publications, Albany, NY. ( HL7V3.0 )] (UMLS (HL7) C1137110) =Intellectual Product =Code;
CodeSystem | - 199. IDENTITY DISORDER
- (UMLS (ICD9CM) C0020795) =Mental or Behavioral Dysfunction
|
- 150. ICD-10 Australian modification
- (UMLS (HL7) C1550218) =Intellectual Product =Code;
| - 200. Identity May Be Divulged
- (UMLS (HL7) C1547649) =Idea or Concept =HL7 Vocabulary Version 2.5;
=No;
Yes;
Not applicable;
|
home
